| abstract |
It has been found in the present invention that renin-angiotensin-based inhibitors are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, it can be used in connection with the treatment of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of contractile disease or cachexia and is therefore useful for the treatment of symptoms or signs of aging. It may also be used to enhance the function of healthy subjects. |